sever
acut
respiratori
syndrom
coronaviru
progress
pandem
associ
substanti
morbid
mortal
unit
state
center
diseas
control
prevent
cdc
issu
interim
clinic
guidanc
manag
patient
confirm
coronaviru
diseas
limit
data
virolog
clinic
characterist
prognosi
sever
total
patient
sever
divid
good
poor
recoveri
group
dynam
viral
shed
serolog
characterist
explor
risk
factor
associ
poor
recoveri
lung
lesion
resolut
identifi
addit
potenti
relationship
among
viral
shed
proinflammatori
respons
lung
lesion
evolut
character
total
patient
poor
recoveri
like
prolong
interv
viral
shed
longest
viral
shed
day
symptom
onset
older
age
hyperlipemia
hypoproteinemia
corticosteroid
therapi
consolid
chest
computedtomographi
ct
prolong
igm
posit
associ
poor
recoveri
addit
odd
impair
lung
lesion
resolut
higher
patient
hypoproteinemia
hyperlipemia
elev
level
ferritin
final
viral
shed
proinflammatori
respons
close
correl
lung
lesion
evolut
chest
ct
medrxiv
preprint
patient
sever
prolong
infect
delay
intermitt
viral
shed
older
age
hyperlipemia
hypoproteinemia
corticosteroid
usag
prolong
igm
posit
might
util
predic
factor
patient
poor
recoveri
recov
would
help
address
question
also
alter
us
current
criteria
hospit
discharg
may
need
reevalu
retrospect
observ
studi
sever
case
wuhan
china
focus
virolog
clinic
characterist
investig
uncov
natur
histori
singlecent
observ
studi
perform
union
hospit
within
tongji
medic
colleg
huazhong
univers
scienc
technolog
hust
studi
adult
patient
infect
hospit
februari
fortyeight
patient
classifi
laboratoryconfirm
case
diagnosi
base
posit
viral
nucleicacid
test
result
throatswab
sampl
wherea
remain
two
patient
clinic
diagnos
case
viral
nucleicacid
test
neg
diagnosi
made
base
symptom
exposur
histori
presenc
lungimag
featur
consist
coronaviru
pneumonia
two
clinic
diagnos
patient
later
confirm
use
serolog
test
medic
record
februari
march
sever
ill
patient
analyz
patient
divid
either
good
poor
recoveri
group
accord
clinic
outcom
march
addit
patient
also
divid
lung
lesion
partial
resolutionpati
group
lung
lesion
signific
resolutionpati
group
base
latest
chest
ct
scan
march
march
studi
approv
ethic
commiss
union
hospit
tongji
medic
colleg
hust
written
inform
consent
obtain
directli
patient
detail
data
sourc
procedur
nucleicacid
amplif
serolog
test
treatment
clinic
outcom
definit
studi
provid
supplementari
appendix
continu
variabl
descript
data
express
appropri
mean
standard
deviat
median
interquartil
rang
iqr
categor
variabl
summar
count
percentag
categori
pearson
test
pearson
test
continu
correct
fisher
exact
test
util
appropri
compar
differ
patient
good
recoveri
poor
recoveri
analys
perform
use
r
statist
packag
version
fifti
patient
enrol
studi
februari
total
male
femal
median
age
year
iqr
year
half
patient
underli
disord
includ
hypertens
diabet
coronari
heart
diseas
chronic
obstruct
pulmonari
diseas
copd
among
disord
patient
experienc
symptom
fatigu
fever
cough
patient
short
breath
upon
admiss
tabl
patient
exhibit
lymphopenia
upon
admiss
common
complic
hospit
electrolyt
disord
coagulopathi
dyslipidemia
hypoproteinemia
liver
dysfunct
importantli
hyperlipidemia
hypoproteinemia
liver
injuri
frequent
observ
patient
poor
recoveri
tg
lactatdehydrogenas
ldh
level
normal
rang
addit
coagul
disord
commonli
seen
patient
poor
recoveri
frequenc
fibrogen
fib
elev
differ
greatli
two
group
tabl
addit
patient
poor
recoveri
higher
frequenc
corticosteroid
therapi
albumin
administr
patient
good
recoveri
tabl
odd
poor
recoveri
higher
patient
older
age
hypoproteinemia
hyperlipemia
corticosteroid
therapi
tabl
march
median
time
admiss
discharg
day
iqr
day
total
patient
discharg
wherea
patient
still
hospit
multifoc
lesion
chest
ct
total
viral
nucleicacid
test
perform
explor
viral
shed
diseas
cours
viral
detect
posit
rate
differ
differ
specimen
type
vari
day
onset
diseas
supplementari
tabl
dynam
pattern
viral
shed
show
patient
intermitt
viru
shed
intriguingli
two
patient
signific
clinic
improv
viral
nucleicacid
test
remain
posit
day
march
median
durat
viral
shed
day
iqr
day
symptom
onset
longest
durat
viral
shed
day
figur
interv
first
last
posit
pcr
assay
result
day
extens
prolong
patient
poor
recoveri
addit
serolog
test
also
differ
greatli
two
group
presenc
prolong
igm
close
associ
poor
recoveri
patient
total
patient
good
recoveri
posit
igg
neg
igm
hospit
one
month
contrast
patient
poor
recoveri
posit
test
result
igm
igg
march
longest
durat
igm
day
onset
ill
indic
sever
patient
poor
recoveri
like
prolong
acut
phase
ill
figur
total
chest
ct
imag
result
collect
continu
monitor
diseas
cours
common
pattern
seen
initi
chest
ct
scan
bilater
lung
involv
groundglass
opac
ggo
consolid
tabl
supplementari
figur
importantli
patient
poor
recoveri
like
persist
lung
damag
diffus
pattern
ggo
multifoc
consolid
consolid
pattern
close
associ
poor
outcom
patient
tabl
lesion
gradual
absorb
residu
ggo
consolid
interstiti
abnorm
lung
fibrosi
observ
supplementari
figur
patient
good
recoveri
group
signific
improv
chest
ct
prior
hospit
discharg
contrast
lung
lesion
resolut
extens
delay
patient
poor
recoveri
next
sever
stage
defin
explor
pattern
lung
lesion
evolut
includ
severest
stage
partial
resolut
signific
resolut
complet
resolut
common
pattern
evolut
initi
progress
severest
stage
follow
partial
resolut
signific
resolut
expect
durat
severest
stage
lung
lesion
resolut
markedli
extend
patient
impair
lung
lesion
resolut
supplementari
figur
addit
odd
impair
lung
lesion
resolut
higher
patient
hypoproteinemia
hyperlipemia
particular
liver
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
injuri
increas
level
tg
decreas
level
albumin
commonli
seen
patient
impair
lung
lesion
resolut
tabl
explor
inflammatoryrespons
prolif
severecondit
patient
laboratori
data
inflammatori
responserel
biomark
hospit
examin
found
patient
ferritin
crp
esr
level
normal
rang
tabl
contrast
level
within
normal
rang
patient
intriguingli
higher
level
crp
esr
ferritin
hscrp
often
seen
patient
poor
recoveri
tabl
dynam
inflammatoryrespons
prolif
close
associ
evolut
lung
lesion
chest
ct
inde
patient
impair
lung
lesion
resolut
like
activ
inflammatori
respons
indic
higher
level
ferritin
serum
tabl
next
explor
potenti
role
inflammatori
respons
viral
clearanc
lung
lesion
resolut
clinic
detail
patient
longest
durat
viral
shed
examin
patient
viral
shed
occur
day
persist
viral
shed
could
observ
day
indic
activ
viru
replic
meanwhil
excess
product
cytokin
observ
day
rapid
progress
peak
stage
day
importantli
extens
lung
damag
observ
chest
ct
day
lesion
steadili
resolv
day
signific
improv
day
figur
similar
pattern
could
also
observ
patient
supplementari
figur
thu
day
viral
shed
concentr
significantli
correl
lung
lesion
evolut
chest
ct
sever
patient
also
suggest
patient
poor
recoveri
like
prolong
activ
phase
viral
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
infect
consequ
proinflammatori
respons
promot
lead
lung
lesion
resolut
potenti
viral
clearanc
although
lethal
lower
sarscov
approxim
merscov
approxim
rapidli
spread
result
worldwid
pandem
scope
develop
pandem
much
sever
sar
mer
compar
viral
shed
day
symptom
onset
sar
viral
shed
variabl
even
longer
moreov
nucleicacid
continu
report
still
detect
patient
discharg
clinic
recoveri
howev
case
sar
mer
nucleicacid
therefor
retrospect
singlecent
observ
studi
perform
provid
clinic
evid
determin
virolog
characterist
found
clinic
recoveri
patient
typic
occur
viral
clear
patient
good
recoveri
howev
also
found
viral
shed
could
persist
interv
day
despit
clinic
improv
although
zhou
et
al
report
median
durat
viral
shed
day
iqr
day
survivor
durat
viral
shed
found
greatli
extend
present
studi
median
durat
day
symptom
onset
iqr
day
differ
might
due
specimen
collect
diseas
sever
immunolog
respons
corticosteroid
usag
antivir
treatment
durat
observ
window
variou
popul
observ
studi
conduct
patient
sampl
consecut
collect
upper
respiratori
tract
gastrointestin
tract
improv
detect
cours
diseas
clinic
data
thu
provid
convinc
evid
dynam
viral
shed
pictur
sever
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
infect
patient
addit
found
interv
viral
shed
patient
poor
recoveri
markedli
prolong
importantli
igm
igg
patient
poor
recoveri
remain
posit
late
stage
diseas
indic
patient
might
activ
viral
replic
upper
airway
persist
viral
shed
might
directli
link
poor
recoveri
patient
support
notion
found
rna
could
persist
death
nonsurvivor
base
delay
interv
viral
shed
pattern
serolog
featur
propos
severecondit
patient
may
need
least
three
neg
pcr
result
interv
day
addit
dynam
detect
improv
presenc
igmneg
also
evalu
guid
discharg
plan
patient
similar
sar
mer
cytokin
profil
close
associ
sever
inde
prognost
analysi
found
activ
inflammatori
respons
like
trigger
patient
poor
recoveri
mark
higher
concentr
crp
esr
ferritin
hscrp
suggest
patient
might
proinflammatori
factor
storm
previous
huang
et
al
report
infect
could
initi
increas
secret
cytokin
eg
suppress
inflamm
studi
also
found
sever
patient
poor
recoveri
higher
level
compar
patient
good
recoveri
sinc
level
slightli
elev
patient
specul
might
due
antagonist
effect
activ
phase
proinflammatori
respons
importantli
found
wave
cytokin
storm
typic
occur
activ
phase
viral
infect
prolong
inflammatori
respons
could
observ
sever
patient
poor
recoveri
consequ
excess
inflamm
damag
lung
tissu
subsequ
lung
repair
regener
could
initi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
regard
lung
lesion
could
gradual
resolv
viral
clearanc
might
achiev
corticosteroid
use
frequent
treatment
sever
patient
control
high
amount
cytokin
howev
found
corticosteroid
therapi
close
associ
poor
recoveri
sever
infect
patient
therefor
corticosteroid
administr
great
caution
necessari
addit
viral
shed
risk
factor
slower
recoveri
sever
patient
also
identifi
consist
previou
studi
confirm
older
age
hypoproteinemia
increas
level
ldh
associ
poor
clinic
outcom
patient
particular
older
age
hyperlipemia
hypoproteinemia
corticosteroid
therapi
increas
level
fib
tg
associ
poor
recoveri
patient
uptod
inform
regard
risk
factor
associ
lung
lesion
resolut
severecondit
patient
scarc
clinic
data
studi
suggest
patient
lung
lesion
chest
ct
consolid
pattern
chest
ct
close
associ
poor
recoveri
intriguingli
prognost
factor
includ
hyperlipemia
hypoproteinemia
also
close
link
odd
impair
lung
lesion
resolut
howev
associ
hyperlipidemia
prognosi
report
previou
studi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
report
associ
polymorph
suscept
dyslipidemia
intriguingli
half
patient
current
studi
dyslipidemia
specul
patient
might
particularli
prone
infect
polymorph
might
link
patient
recoveri
thu
studi
need
explor
issu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
declar
compet
interest
patient
public
involv
design
conduct
report
dissemin
plan
research
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
tabl
tabl
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
diseas
cours
day
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
viral
nucleicacid
pcr
test
red
circl
repres
posit
result
viral
nucleicacid
pcr
assay
serolog
test
repres
posit
igm
igg
serolog
test
remain
posit
within
day
symptom
onset
serial
chest
ct
imag
show
dynam
lung
lesion
resolut
day
ill
onset
peripher
predomin
groundglass
opac
diffus
pattern
left
lobe
partial
consolid
right
lower
lobe
day
ill
onset
lung
lesion
steadili
resolv
day
ill
onset
signific
improv
chest
ct
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
